← Eichor
Condition: Merkel Cell Carcinoma Stage Ii Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Merkel Cell Carcinoma Stage Ii

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors
Phase 1/Phase 2 · 2 location(s) · University of Arizona · NCT06814496Studying Off Label Insurance Coverage for Patients With Cutaneous Cancers a "Filter" Observational Study
Phase N/A · 1 location(s) · Ohio State University Comprehensive Cancer Center · NCT07215988Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC Virus
Phase 2 · 1 location(s) · M.D. Anderson Cancer Center · NCT02479698A Study of Pembrolizumab in Japanese Pediatric Participants With Solid Tumors or Lymphomas and Japanese Adult Participan
Phase 1/Phase 2 · 7 location(s) · Merck Sharp & Dohme LLC · NCT07302347A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
Phase 1/Phase 2 · 13 location(s) · AstraZeneca · NCT07115043Neoadjuvant Merkel Cell Carcinoma Therapy (Tx) With the PD-1 Inhibitor Cemiplimab
Phase 2 · 14 location(s) · Institut für Klinische Krebsforschung IKF GmbH at Krankenhau · NCT07387198Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors
Phase 1/Phase 2 · 1 location(s) · Mayo Clinic · NCT05269381Neoadjuvant Cemiplimab in Newly Diagnosed or Recurrent Stage I-II Merkel Cell Carcinoma and Locoregionally Advanced Cuta
Phase 1 · 1 location(s) · H. Lee Moffitt Cancer Center and Research Institute · NCT04975152Phase II Study of Peptide Receptor Radionuclide Therapy in Combination With Immunotherapy for Patients With Merkel Cell
Phase 2 · 3 location(s) · Weill Medical College of Cornell University · NCT05583708
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.